1. Home
  2. VCYT vs KFY Comparison

VCYT vs KFY Comparison

Compare VCYT & KFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCYT
  • KFY
  • Stock Information
  • Founded
  • VCYT 2006
  • KFY 1969
  • Country
  • VCYT United States
  • KFY United States
  • Employees
  • VCYT N/A
  • KFY N/A
  • Industry
  • VCYT Medical Specialities
  • KFY Diversified Commercial Services
  • Sector
  • VCYT Health Care
  • KFY Consumer Discretionary
  • Exchange
  • VCYT Nasdaq
  • KFY Nasdaq
  • Market Cap
  • VCYT 2.9B
  • KFY 3.4B
  • IPO Year
  • VCYT 2013
  • KFY 1999
  • Fundamental
  • Price
  • VCYT $41.51
  • KFY $64.34
  • Analyst Decision
  • VCYT Buy
  • KFY Buy
  • Analyst Count
  • VCYT 10
  • KFY 2
  • Target Price
  • VCYT $42.40
  • KFY $80.00
  • AVG Volume (30 Days)
  • VCYT 1.0M
  • KFY 427.1K
  • Earning Date
  • VCYT 11-04-2025
  • KFY 12-04-2025
  • Dividend Yield
  • VCYT N/A
  • KFY 2.98%
  • EPS Growth
  • VCYT N/A
  • KFY 33.45
  • EPS
  • VCYT 0.38
  • KFY 4.69
  • Revenue
  • VCYT $495,141,000.00
  • KFY $2,763,755,000.00
  • Revenue This Year
  • VCYT $14.52
  • KFY $4.39
  • Revenue Next Year
  • VCYT $9.90
  • KFY $4.42
  • P/E Ratio
  • VCYT $109.62
  • KFY $13.76
  • Revenue Growth
  • VCYT 16.41
  • KFY 0.93
  • 52 Week Low
  • VCYT $22.61
  • KFY $59.23
  • 52 Week High
  • VCYT $47.32
  • KFY $80.64
  • Technical
  • Relative Strength Index (RSI)
  • VCYT 63.38
  • KFY 33.01
  • Support Level
  • VCYT $35.27
  • KFY $63.97
  • Resistance Level
  • VCYT $46.41
  • KFY $66.65
  • Average True Range (ATR)
  • VCYT 1.92
  • KFY 1.60
  • MACD
  • VCYT 0.62
  • KFY -0.37
  • Stochastic Oscillator
  • VCYT 59.02
  • KFY 3.15

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

About KFY Korn Ferry

Korn Ferry is a consulting firm that powers performance. The Company helps unlock the potential in people and unleash transformation across organizations synchronizing, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. The company's segment includes Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search APAC, Executive Search Latin America, Professional Search & Interim and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.

Share on Social Networks: